Clinical drug investigation. Adis International Ltd Schutte, T, Stege, C A M, Smits, M M, Franssen, L E, Donker, M L & de Leeuw, D C 2022, ' Midostaurin as the Most Likely Cause of Bilateral Adrenal Masses in a Patient with Acute Myeloid Leukemia ', Clinical drug investigation . https://doi.org/10.1007/s40261-022-01186-y
Oostvogels, R, Kneppers, E, Minnema, M C, Doorn, R C, Franssen, L E, Aarts, T, Emmelot, M E, Spierings, E, Slaper-Cortenbach, I, Westinga, K, Goulmy, E, Lokhorst, H M & Mutis, T 2016, ' Efficacy of host-dendritic cell vaccinations with or without minor histocompatibility antigen loading, combined with donor lymphocyte infusion in multiple myeloma patients ', Bone Marrow Transplantation . https://doi.org/10.1038/bmt.2016.250 Bone Marrow Transplantation. Nature Publishing Group Bone Marrow Transplantation, 52, 228–237. Nature Publishing Group
Blood, 128(19), 2297-2306. American Society of Hematology Nijhof, I S, Franssen, L E, Levin, M-D, Bos, G M J, Broijl, A, Klein, S K, Koene, H R, Bloem, A C, Beeker, A, Faber, L M, van der Spek, E, Ypma, P F, Raymakers, R, van Spronsen, D-J, Westerweel, P E, Oostvogels, R, van Velzen, J, van Kessel, B, Mutis, T, Sonneveld, P, Zweegman, S, Lokhorst, H M & van de Donk, N W C J 2016, ' Phase 1/2 study of lenalidomide combined with low-dose cyclophosphamide and prednisone in lenalidomide-refractory multiple myeloma ', Blood, vol. 128, no. 19, pp. 2297-2306 . https://doi.org/10.1182/blood-2016-07-729236 Blood, 128(19), 2297-2306. The American Society of Hematology
Oncotarget, 9(74), 34009-34021. Impact Journals Franssen, L E, Nijhof, I S, Bjorklund, C C, Chiu, H, Doorn, R, Van Velzen, J, Emmelot, M, Van Kessel, B, Levin, M D, Bos, G M J, Broijl, A, Klein, S K, Koene, H R, Bloem, A C, Beeker, A, Faber, L M, Van Der Spek, E, Raymakers, R, Sonneveld, P, Zweegman, S, Lokhorst, H M, Thakurta, A, Qian, X, Mutis, T & Van De Donk, N W C J 2018, ' Lenalidomide combined with low-dose cyclophosphamide and prednisone modulates Ikaros and Aiolos in lymphocytes, resulting in immunostimulatory effects in lenalidomide-refractory multiple myeloma patients ', Oncotarget, vol. 9, no. 74, pp. 34009-34021 . Oncotarget Oncotarget, 9(74), 34009-34021. Impact Journals LLC Oncotarget, 9(74), 34009. Impact Journals
Haematologica, 103(8), e368. Ferrata Storti Foundation Haematologica, 103(8), e368-e371. Ferrata Storti Foundation Haematologica, 103(8), E368-E371. Ferrata Storti Foundation Franssen, L E, Nijhof, I S, Couto, S, Levin, M D, Bos, G M J, Broijl, A, Klein, S K, Ren, Y, Wang, M, Koene, H R, Bloem, A C, Beeker, A, Faber, L M, van der Spek, E, Raymakers, R, Leguit, R J, Sonneveld, P, Zweegman, S, Lokhorst, H, Mutis, T, Thakurta, A, Qian, X & van de Donk, N W C J 2018, ' Cereblon loss and up-regulation of c-Myc are associated with lenalidomide resistance in multiple myeloma patients ', Haematologica, vol. 103, no. 8, pp. e368-e371 . https://doi.org/10.3324/haematol.2017.186601 Haematologica-the Hematology Journal, 103(8), E368-E371. Ferrata Storti Foundation